Product Information

CLINDAMYCIN HCL 300 MG CAPSULE is a generic product labeled by AvPAK, priced at $0.1684 per EA under NDC 50268018515. Its NADAC has been published 289 times since Feb 10, 2021.

FDA first approved this application on Nov 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN HCL 300 MG CAPSULE

Clindamycin hydrochloride
$0.1684per EA

Strength

300 mg/1

Manufacturer

AvPAK

NDC

50268018515

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CLINDAMYCIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207402

FDA Approved

11/5/2018

TE Code

AB

On Market Since

10/27/2020

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has been published 289 times since Feb 10, 2021, and over the history we have for it it has declined 36.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1684 per EA
All-time high$0.2913 (Jun 16, 2021)
All-time low$0.1674 (Nov 20, 2024)
52-week high$0.1895
52-week low$0.1680
Median price$0.2339
Average price$0.2257
Largest weekly change+33.6% (Aug 21, 2024)
Weeks tracked289
Tracking sinceFeb 10, 2021

Price History

1W

+0.2%

1M

+0.2%

3M

-4.2%

6M

-6.1%

1Y

-11.1%

3Y

-33.4%

5Y

-36.7%

All

-36.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN HCL 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 300 MG CAPSULE, manufactured by AvPAK, is $0.1684 per EA (NDC 50268018515), effective Aug 19, 2026.

How has the price of CLINDAMYCIN HCL 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has declined 36.1%. It has been tracked across 289 weekly CMS publications since Feb 10, 2021.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 300 MG CAPSULE?

Since Feb 10, 2021, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has ranged from a low of $0.1674 (Nov 20, 2024) to a high of $0.2913 (Jun 16, 2021), with a median of $0.2339 per EA.

Are there cheaper alternatives to CLINDAMYCIN HCL 300 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN HCL 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CLINDAMYCIN HCL 300 MG CAPSULE?

CLINDAMYCIN HCL 300 MG CAPSULE (NDC 50268018515) is labeled by AvPAK, and CMS classifies it as a generic product.